6beta-Azido-7alpha-hydroxy-17-oxo-5alpha-androstan-3beta-yl acetate.

Area of Science:

• Medicinal Chemistry
• Structural Biology
• Computational Chemistry

Background:

• Aromatase inhibitors are crucial in treating hormone-dependent cancers.
• Understanding the precise three-dimensional structure of potential inhibitors is key to optimizing their efficacy.
• Steroid nucleus conformation influences biological activity.

Purpose of the Study:

• To elucidate the crystal structure of the novel compound C21H31N3O4.
• To investigate the conformational characteristics of the steroid nucleus and its substituents.
• To computationally model the molecule's geometry and identify factors influencing its conformation.

Main Methods:

• X-ray crystallography was employed to determine the solid-state structure.
• Conformational analysis of the fused ring system (A, B, C, D) was performed.
• Ab initio quantum mechanical calculations were used to model the equilibrium geometry.

Main Results:

• The compound C21H31N3O4, a potential aromatase inhibitor, exhibits a trans-fused ring system.
• Rings A, B, and C adopt slightly flattened chair conformations, while Ring D shows a 14alpha-envelope conformation.
• A small twist in the steroid nucleus, quantified by a specific torsion angle, was observed and reproduced by computational analysis.
• The observed twist is attributed to the steric influence of the 6beta-azide substituent.

Conclusions:

• The determined structure provides valuable insights into the molecular architecture of this potential aromatase inhibitor.
• The conformational flexibility and specific twist of the steroid nucleus may be critical for its interaction with the aromatase enzyme.
• Computational methods effectively predict structural features, aiding in the design of future inhibitors.